Depo-Provera Linked to Increased HIV Risk in Africa

Medscape, January 09, 2015

The injectable contraceptive depot medroxyprogesterone (Depo-Provera or DMPA) is associated with elevated risk for HIV infection among women in low-income or middle-income countries of sub-Saharan Africa, according to a study.

The mechanism behind a link between DMPA and HIV infection is not known.

Read more here